The Venture Codex Logo

The Venture Codex

Vivo Capital

192 Lytton Avenue, Palo Alto, CA, 94301, United States

Overview

Global investment firm focused on healthcare across multiple fund strategie

Founded

1996

Deals · 12mo

12

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B
Series C

Geographic focus

China
United States

Sector focus

Finance
Financial Services
Health Care
Venture Capital

Investment portfolio

111rounds
NAMEDATESIZE
Expedition Therapeutics
Aug 2026Participated
$115 MSeries B
Mentari Therapeutics
Jul 2026Participated
$200 MOther Equity
Serapha Bio
Jun 2026Participated
$138 MSeries A
Mentari Therapeutics
May 2026Participated
$290 MOther Equity
Full-Life Technologies
May 2026Led
$150 MSeries D
Immunocan
May 2026Led
$37 MSeries A
Oricell Therapeutics
Apr 2026Led
$110 MOther Equity
Candid Therapeutics
Mar 2026Participated
$505 MOther Equity
Kinaset Therapeutics
Jan 2026Participated
$103 MSeries B
EpiBiologics
Jan 2026Participated
$107 MSeries B
BlossomHill Therapeutics
Dec 2025Participated
$84 MSeries B
Sanegene Bio
Dec 2025Participated
$110 MSeries B
Expedition Therapeutics
Aug 2026Participated
$115 MSeries B
Mentari Therapeutics
Jul 2026Participated
$200 MOther Equity
Serapha Bio
Jun 2026Participated
$138 MSeries A
Mentari Therapeutics
May 2026Participated
$290 MOther Equity
Full-Life Technologies
May 2026Led
$150 MSeries D
Immunocan
May 2026Led
$37 MSeries A
Oricell Therapeutics
Apr 2026Led
$110 MOther Equity
Candid Therapeutics
Mar 2026Participated
$505 MOther Equity
Kinaset Therapeutics
Jan 2026Participated
$103 MSeries B
EpiBiologics
Jan 2026Participated
$107 MSeries B
BlossomHill Therapeutics
Dec 2025Participated
$84 MSeries B
Sanegene Bio
Dec 2025Participated
$110 MSeries B
111
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Vivo Capital: 111 funding rounds are recorded in the selected participation categories.All available history.
Vivo Capital: 111 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A713
Series B728
Series C+929
Other Equity414

Monthly Deal Activity

Vivo Capital: 111 deals are recorded across 151 months.All available history.
Vivo Capital: 111 deals are recorded across 151 months. All available history
MonthDeals
Apr '142
May '141
Jun '140
Jul '140
Aug '140
Sep '140
Oct '140
Nov '140
Dec '141
Jan '150
Feb '150
Mar '150
Apr '151
May '151
Jun '150
Jul '150
Aug '150
Sep '150
Oct '150
Nov '151
Dec '150
Jan '160
Feb '160
Mar '161
Apr '161
May '160
Jun '160
Jul '161
Aug '160
Sep '163
Oct '160
Nov '161
Dec '161
Jan '170
Feb '170
Mar '170
Apr '170
May '171
Jun '172
Jul '171
Aug '172
Sep '170
Oct '171
Nov '173
Dec '170
Jan '180
Feb '181
Mar '181
Apr '181
May '180
Jun '183
Jul '180
Aug '181
Sep '181
Oct '181
Nov '180
Dec '181
Jan '190
Feb '192
Mar '192
Apr '191
May '190
Jun '190
Jul '192
Aug '190
Sep '191
Oct '192
Nov '190
Dec '190
Jan '204
Feb '201
Mar '200
Apr '202
May '200
Jun '200
Jul '203
Aug '201
Sep '200
Oct '203
Nov '201
Dec '201
Jan '214
Feb '210
Mar '215
Apr '210
May '214
Jun '211
Jul '210
Aug '211
Sep '213
Oct '211
Nov '211
Dec '210
Jan '220
Feb '220
Mar '221
Apr '220
May '220
Jun '221
Jul '222
Aug '220
Sep '220
Oct '220
Nov '222
Dec '221
Jan '230
Feb '231
Mar '230
Apr '230
May '230
Jun '231
Jul '231
Aug '232
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '242
Mar '240
Apr '240
May '242
Jun '240
Jul '240
Aug '240
Sep '241
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '250
Dec '252
Jan '262
Feb '260
Mar '261
Apr '261
May '263
Jun '261
Jul '261
Aug '261
Sep '260
Oct '260

Sector Breakdown

Vivo Capital: Health & Life Sciences is the largest displayed sector by deal count (110 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Vivo Capital: Health & Life Sciences is the largest displayed sector by deal count (110 deals). All available history
SectorDeals
Health & Life Sciences110
Consumer & Lifestyle4
Networks, Cloud & Communication4
Hardware & Robotics3
Enterprise Software3
Manufacturing3
Professional Services3
AI & Machine Learning2
Space & Frontier Tech2
Marketing & Advertising1
Government & Defense1
Data, Analytics & IT1

Deal Size Distribution

Vivo Capital: 111 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Vivo Capital: 111 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M1
$10M-$25M6
$25M-$50M18
$50M-$100M44
$100M-$250M37
$250M-$500M3
$500M-$1B1
$1B+0

Deals By Geography

Vivo Capital: United States has the largest recorded deal count among the displayed regions (91 deals).All available history.

Top 5 of 5 regions; European countries are grouped as Europe.

Vivo Capital: United States has the largest recorded deal count among the displayed regions (91 deals). All available history
RegionDeals
United States91
China14
Europe4
Singapore1
Brazil1
Vivo Capital: 20 co-investors are shown, with OrbiMed sharing 24 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Vivo Capital: 20 co-investors are shown, with OrbiMed sharing 24 recorded deals. All available history
Co-investorShared deals
OrbiMed24
RA Capital Management22
venBio Partners20
Cormorant Asset Management19
Janus Henderson Investors17
Lilly Asia Ventures16
Venrock15
Logos Capital14
Novo Holdings13
Wellington Management10
Perceptive Advisors9
Rock Springs Capital9
Samsara BioCapital9
Deerfield Management8
RTW Investments8
Surveyor Capital8
Boxer Capital7
Longitude Capital7
Sofinnova Ventures7
5AM Ventures6

Investment Strategy

Vivo Capital: Led accounts for 24% and participating for 76% of round participation.All available history.
Vivo Capital: Led accounts for 24% and participating for 76% of round participation. All available history
CategoryDeals (count)Share (%)
Led2724%
Participating8476%
Vivo Capital: Single-lead accounts for 52% and co-led for 48% of lead dynamics.All available history.
Vivo Capital: Single-lead accounts for 52% and co-led for 48% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1452%
Co-led1348%

Team

Chloe Zhang

Principal

Edgar G. Engleman

Co - Founder & Managing Partner

Frank Kung

Managing Partner

Gaurav Aggarwal
Joseph Siletto

Managing Director

Michael Chang

Managing Partner

Mitchell Mutz

Entrepreneur Partner

Shan Fu

Managing Partner

Tiantian Zhu

Associate